781 related articles for article (PubMed ID: 24956189)
21. Obesity and ECG left ventricular hypertrophy.
Muiesan ML; Salvetti M; Di Castelnuovo A; Paini A; Assanelli D; Costanzo S; Badilini F; Vaglio M; Donati MB; Agabiti Rosei E; de Gaetano G; Iacoviello L;
J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
[TBL] [Abstract][Full Text] [Related]
22. Paced QT interval is a better predictor of mortality than the intrinsic QT interval: long-term follow-up study.
Lee JM; Janardhan AH; Kang KW; Joung B; Pak HN; Sundaram S; Choe WC; Lee MH; Hwang HJ
Heart Rhythm; 2014 Jul; 11(7):1184-9. PubMed ID: 24726972
[TBL] [Abstract][Full Text] [Related]
23. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
[TBL] [Abstract][Full Text] [Related]
24. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
[TBL] [Abstract][Full Text] [Related]
25. Population-based study of QT interval prolongation in patients with rheumatoid arthritis.
Chauhan K; Ackerman MJ; Crowson CS; Matteson EL; Gabriel SE
Clin Exp Rheumatol; 2015; 33(1):84-9. PubMed ID: 25572282
[TBL] [Abstract][Full Text] [Related]
26. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
[TBL] [Abstract][Full Text] [Related]
27. Electrocardiogram Performance in the Diagnosis of Left Ventricular Hypertrophy in Hypertensive Patients With Left Bundle Branch Block.
Burgos PF; Luna Filho B; Costa FA; Bombig MT; Souza D; Bianco HT; Oliveira Filho JA; Izar MC; Fonseca FA; Póvoa R
Arq Bras Cardiol; 2017 Jan; 108(1):47-52. PubMed ID: 27992034
[TBL] [Abstract][Full Text] [Related]
28. Use of tricyclic antidepressants as analgesic adjuvants results in nonhazardous prolongation of the QTc interval.
Funai Y; Funao T; Ikenaga K; Takahashi R; Hase I; Nishikawa K
Osaka City Med J; 2014 Jun; 60(1):11-9. PubMed ID: 25272563
[TBL] [Abstract][Full Text] [Related]
29. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.
Rich JD; Thenappan T; Freed B; Patel AR; Thisted RA; Childers R; Archer SL
Int J Cardiol; 2013 Aug; 167(3):669-76. PubMed ID: 22459397
[TBL] [Abstract][Full Text] [Related]
30. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
[TBL] [Abstract][Full Text] [Related]
31. Prolonged QT interval diagnosis suppression by a widely used computerized ECG analysis system.
Garg A; Lehmann MH
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):76-83. PubMed ID: 23275261
[TBL] [Abstract][Full Text] [Related]
32. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?
Antikainen RL; Grodzicki T; Palmer AJ; Beevers DG; Webster J; Bulpitt CJ;
J Hum Hypertens; 2006 Jun; 20(6):451-9. PubMed ID: 16708082
[TBL] [Abstract][Full Text] [Related]
34. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients.
Vernooij JW; Cramer MJ; Visseren FL; Korndewal MJ; Bots ML; Meijs MF; Doevendans PA; Spiering W;
Am J Cardiol; 2012 Jul; 110(2):227-33. PubMed ID: 22483385
[TBL] [Abstract][Full Text] [Related]
35. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
[TBL] [Abstract][Full Text] [Related]
36. Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients.
Kim SJ; Oh HJ; Yoo DE; Shin DH; Lee MJ; Kim HR; Park JT; Han SH; Yoo TH; Choi KH; Kang SW
PLoS One; 2012; 7(4):e35534. PubMed ID: 22530043
[TBL] [Abstract][Full Text] [Related]
37. Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure.
Pontiroli AE; Pizzocri P; Saibene A; Girola A; Koprivec D; Fragasso G
Int J Obes Relat Metab Disord; 2004 Sep; 28(9):1118-23. PubMed ID: 15263923
[TBL] [Abstract][Full Text] [Related]
38. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
[TBL] [Abstract][Full Text] [Related]
39. Interrelation Between Electrocardiographic Left Atrial Abnormality, Left Ventricular Hypertrophy, and Mortality in Participants With Hypertension.
Ahmad MI; Mujtaba M; Anees MA; Li Y; Soliman EZ
Am J Cardiol; 2019 Sep; 124(6):886-891. PubMed ID: 31324356
[TBL] [Abstract][Full Text] [Related]
40. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
